RxDoctor Payments Data

James Ogilvie

Pediatric Orthopaedic Surgery · Salt Lake City, UTNPI 1154497006

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $1,662,015 of the $1,662,027 with a category attached, or 100.0%. Medtronic accounts for 99.4% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2019 at $516,233 and has fallen 99.9% since, to $550 in 2025.

$1,662,027in general payments, 2019–2025

Across 81 payments — averaging $20,519 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$1.7M
  • Ortho Development Corporation$9K
  • GSK$13

What the payments were for

  • Royalty or licence$1,662,015100%
  • Food & beverage$130%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Medtronic(2 entities)16$1,652,675
Ortho Development Corporation64$9,340
GSK1$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few pediatric orthopaedic surgery providers in Utahto place this figure against a meaningful peer group, so we don't.

Other pediatric orthopaedic surgery in Salt Lake City

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →